Free animal vaccination camps across India by Indian Immunologicals on ‘World Zoonosis Day’
- Around 50,000 free doses administered by IIL at 170+ Vaccination camps in20 States & UTs
- World Zoonosis Day (July 6), the company organized Free Vaccination Camps for animals in Chennai, Tirunelveli, Trichy, Coimbatore, Madurai, Vellore and states today
- India accounts for 36% of deaths due to Rabies (Zoonotic Disease) – the highest in the world
Chennai, July 6, 2019: Indian
Immunologicals Limited (IIL), a leading biologicals company, today organized free Vaccination Camps in over 170 centres
across the country. The market leader in veterinary biologicals and one of
the largest animals & human health players in India, IIL has been organizing
these Vaccination and Rabies awareness camps at Veterinary dispensaries, NGOs
and Veterinarians across the country every year on “World Zoonosis Day” which
is observed every year on the 6th of July. Around 50,000 doses of RAKSHARAB (anti-rabies vaccine)produced by IILwas administered
free of cost in as many as 20 states
and Union Territories through veterinary dispensaries, NGOs etc.
Vaccination of a Canine
|
Diseases that
transmit from animals to human beings are called Zoonotic diseases and 70% of
all emerging diseases that affect humans are zoonotic in nature. In India, occurrence
of Rabies is prevalent and accounts for more than 90% of all zoonotic cases
reported in the country. The World Health Organisation (WHO) estimates around 1.75
million dog bite cases every year causing around 59,000 deaths worldwide each
year with majority of cases (95%) taking place in Africa and Asia. A 2015
study, published in peer-reviewed PLOS Neglected Tropical Diseases estimates
about 20,800 rabies deaths every year in India - the highest in the world at
36% of total deaths due to rabies.
The economic cost
of dog mediated rabies has been estimated to be $ 8.6 billion. The high
incidence of rabies in India is due to large uncontrolled stray dog population
in India. Stray dogs account for nearly 80%
of the canine population in India. There are several reasons for the high
incidence including poor vaccination. Prophylaxis through vaccination is the
most cost-effective intervention to reduce incidence of disease. Several
countries have been able to reduce the number of rabies related human deaths
through vaccination of dogs.
On the occasion
of World Zoonosis Day, Dr.K. Anand Kumar, Managing Director, Indian
Immunologicals Limited said, “IIL is truly a One Health company, playing
a significant role in providing cost effective tools for the control of various
zoonotic diseases in the country including the dreaded Rabies. Working with
various other stake holders including the common public, IIL is determined to
eradicate disease.”
“IIL wishes to
spread the message that preventive vaccination is a proven and cost-effective
means to minimize incidence of zoonotic diseases. Effective implementation of
Swachh Bharat programme and preventive vaccination would vastly improve the
health status of the country,” added Dr.Prasanna Deshpande, Deputy Managing Director, Indian
Immunologicals Limited.
In addition to
Rabies, other Zoonotic diseases such as Brucellosis, Leptospirosis, Swine Flu,
Porcine Cysticercosis, Nipah, Zika etc. also affect human beings. Awareness,
accurate diagnosis, improvement in sanitary conditions, prophylactic
vaccination are all measures that need to be taken to restrain/eradicate
spread.
Indian Immunologicals
Limited (a subsidiary company of National Dairy Development Board) is leading
biologicals manufacturer. Through extensive research, the company has delivered
affordable vaccines for the consumers in India. IIL continues to be a leading
manufacturer of animal rabies vaccine (Raksharab) and human rabies vaccine
(Abhayrab) in the country. IIL’s CYSVAX is the world’s first vaccine for Porcine
Cysticercosisin Pigs. Cysticercosis is a very important zoonotic disease and it
is understood that it is a prime cause of epilepsy in humans. Vaccinating Pigs
against Porcine Cysticercosis can help significantly reduce the incidence of
epilepsy in humans.